![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Decision Diagnostics Files Suit Against J&J Over Glucose Strip Patents
Decision Diagnostics Files Suit Against J&J Over Glucose Strip Patents
![GavelwithBaseBW.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/GavelwithBaseBW.gif?t=1579650370&width=430)
Decision Diagnostics’ subsidiaries Decision IT and Pharma Tech Solutions have filed a patent infringement suit against Johnson & Johnson and two of its Lifescan units.
The suit involves LifeScan’s OneTouch Ultra glucose testing strips. The plaintiffs are seeking between $400 million and $700 million for alleged infringement of the ’069 and ’411 patents.
The suit was filed Monday in the U.S. District Court for the District of Nevada. — Anisa Jibrell
Upcoming Events
-
21Oct